WHO issues guidelines for GLP-1 receptor agonists in obesity The World Health Organization introduced guidelines to aid clinicians in the use of glucagon-like peptide-1 receptor agonists to treat obesity
No absolute contraindication exists based on current evidence, but the limited human data during lactation means most medical providers recommend consulting your obstetrician and lactation specialist before deciding
Consistent results depend on adherence, nutrition choices, and your body's individual response pattern
Taking creatine at any time of the day may cause water retention, which can result in temporary weight gain
Its important to remember that injecting semaglutide is typically done subcutaneously (under the skin), and you can choose different injection sites based on your comfort
The drug delays gastric emptying, increases satiety and improves energy utilization